Publication:
Synthesis, characterization and inhibitor properties of benzimidazolium salts bearing 4-(methylsulfonyl)benzyl side arms

dc.contributor.authorGüzel, Abdussamat
dc.contributor.authorNoma, Samir Abbas Ali
dc.contributor.authorŞen, Betül
dc.contributor.authorKazancı, Ali
dc.contributor.authorTaşkın-Tok, Tuğba
dc.contributor.authorKolac, Turgay
dc.contributor.authorAktaş, Aydın
dc.contributor.authorAtes, Burhan
dc.contributor.authorAygün, Muhittin
dc.contributor.authorGök, Yetkin
dc.contributor.buuauthorNOMA, Samir Abbas Ali
dc.contributor.departmentBursa Uludağ Üniversitesi/Fen-Edebiyat Fakültesi/Kimya Bölümü.
dc.contributor.researcheridABH-1773-2021
dc.date.accessioned2024-11-18T07:18:55Z
dc.date.available2024-11-18T07:18:55Z
dc.date.issued2022-10-26
dc.description.abstractHerein, a series of N-heterocyclic carbene (NHC) precursors bearing sulfonyl moieties was prepared. 1-(4-(methylsulfonyl)benzyl)-3-alkylbenzimidazolium chloride salts were synthesized with the reaction of 1-alkylbenzimidazoles with 4-(methylsulfonyl)benzyl chloride. These compounds were characterized by using 1 H NMR, 13 C NMR, FT-IR spectroscopy and elemental analysis techniques. Molecular and crystal structures of compounds 2e and 2j were determined by using the single-crystal X-ray diffraction method. Furthermore, enzyme inhibitory properties of benzimidazolium salt were tested against xanthine oxidase (XO) and acetylcholinesterase (AChE), then determined the IC50 value range of XO were determined from 0.218 to 1.927 mu M, while the IC50 for AChE were determined from 1.328 to 5.22. Docking applications were used by using AutoDock4 in order to define the binding pose of the selected compounds, ( 2c, 2d and 2g ) and also to visualize the correlation of the generated optimal complexes. It is found that the compound 2g has good binding affinity (-11.24 kcal/mol) against AChE, on the other side, compound 2c shows the lowest binding energy (-8.32 kcal/mol) for the XO target. These findings and the defined compounds could be as potential agents to develop effective medicine for AChE and XO in the future.(c) 2022 Elsevier B.V. All rights reserved.
dc.description.sponsorshipInonu University - FOA-2020-2240 - FDK-2022-2950
dc.description.sponsorshipDokuz Eylül Üniversitesi (University Research Grant) - 2010.KB.FEN.13
dc.identifier.doi10.1016/j.molstruc.2022.134320
dc.identifier.issn0022-2860
dc.identifier.urihttps://doi.org/10.1016/j.molstruc.2022.134320
dc.identifier.urihttps://www.sciencedirect.com/science/article/pii/S0022286022019706?via%3Dihub
dc.identifier.urihttps://hdl.handle.net/11452/47968
dc.identifier.volume1273
dc.identifier.wos000904967000003
dc.indexed.wosWOS.SCI
dc.language.isoen
dc.publisherElsevier
dc.relation.journalJournal of Molecular Structure
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectMetal-complexes
dc.subjectPrecursors synthesis
dc.subjectCarbonic-anhydrase
dc.subjectCrystal-structure
dc.subjectXanthine
dc.subjectLigands
dc.subjectSystem
dc.subjectSet
dc.subjectAcetylcholinesterase
dc.subjectBenzimidazolium salt
dc.subjectMolecular docking
dc.subjectSulfonyl
dc.subjectSingle -crystal
dc.subjectXanthine oxidase
dc.subjectChemistry
dc.titleSynthesis, characterization and inhibitor properties of benzimidazolium salts bearing 4-(methylsulfonyl)benzyl side arms
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublication08ae8d1b-5dad-4ab3-8186-7723e086d163
relation.isAuthorOfPublication.latestForDiscovery08ae8d1b-5dad-4ab3-8186-7723e086d163

Files

Collections